mortality, and considerable healthcare costs, is become increasingly common, and the prevalence of CKD is estimated more than 10% in the adult population.
Due to the critical clinical implication, the close relationship of NAFLD with CKD has attracted considerable scientific interest.
Accumulating evidence suggests that NAFLD and CKD share multiple common pathogenetic pathways and risk factors (such as insulin resistance, abdominal obesity, and dysglycemia), furtherly supporting the link between NAFLD and CKD. Notably, several studies have argued that the presence of NASH increases the prevalence of CKD, and the severity of liver biopsy-proven NASH histology (fibrosis stage) shows a grading relationship with kidney dysfunction. 7, 8 This association
suggested that biopsy-proven liver fibrosis stage in NAFLD patients may have a potential for identifying CKD. Despite the gold standard for hepatic fibrosis assessment, however, liver biopsy is unfeasible in a clinical setting, due to multiple limitations, including sampling variability, rare but fatal complications, and costs. To this end, it is highly desired to develop an invasive and novel method to stage the severity of liver fibrosis.
Against this, numerous invasive methods for staging of liver fibrosis are continually emerging. 9 Among them, transient elastography (TE), as promising alternatives to liver biopsy, has gained lots of scientific interest. A series of studies have demonstrated that TE has a better performance than serum invasive serum markers for liver fibrosis evaluation, whereas its role in identifying CKD has not yet been established. 10, 11, [12] [13] [14] [15] [16] Therefore, the aim of this study was (1) to assess the performance of liver stiffness measured by TE, as well as several other noninvasive score indices for identifying CKD, and (2) develop a multiple-variable model for CKD risk assessment among individuals with ultrasonography-diagnosed NAFLD.
| MATERIAL S AND ME THODS

| Study population
Clinical and demographic characteristics of subjects were collected from the electronic health record in China-Japan union hospital. Adult patients with ultrasonography-diagnosed NAFLD between April 2015
and August 2017 in China-Japan union hospital of Jilin university were initially eligible (n = 1439). Exclusion criteria included the following:
self-reporting alcohol consumption of more than 30 g or 20 g per day,
respectively, for males and females, positivity for hepatitis C virus antibodies or hepatitis B surface antigen, use of hepatotoxic drugs, autoimmune liver diseases, and other chronic hepatic diseases. According to the exclusion criteria, 24 patients were excluded, and eventually, a total of 1415 patients were included in the study.
| Study size
To calculate the required sample size for the comparison of the area under a ROC curve with a null hypothesis value, the required significance level and power of the test should be taken into account. Thus, this study was designed to have a power of 90% to test the prespecified hypothesis that the noninvasive methods would have an AUC of 0.85 for the detection of CKD under the null hypothesis, at a one-sided type I error rate of 0.05.
Assuming a CKD prevalence of 10%, a sample of 1089 individuals was needed.
| Clinical and laboratory procedures
Information regarding demographics and lifestyle habits (smoking and drinking history) were retrospected collected. Liver ultrasonography scanning was performed by the same experienced hepatologists, who was blinded to participants' details. Liver stiffness was measured by TE using Fibroscan (EchoSens, Paris, France) conducted by an independent operator who was blinded to the clinical data of patients. Blood pressure was measured by a digital electronic sphygmomanometer.
All serological measurements were made after an overnight fast using standardized methods. The diagnosis of fatty liver was on the basis of the criteria proposed by the Asian Pacific Association for Study of the Liver. 17 Diabetes mellitus was diagnosed according to the American Diabetes Association criteria. 18 Hypertension was defined according to JNC 7 criteria. AST/ALT ratio, liver stiffness, and multivariate model for assessing the risk of CKD were compared using the comparison of the AUROCs. All statistical analyses were performed using MedCalc and R package for windows.
| RE SULTS
| Patient characteristics
A total of 1439 patients were initially eligible. Twenty-four patients were excluded according to the exclusion criteria for a total of 1415 patients for inclusion in the study ( Figure 1 ). 
| Univariate analysis of the association of noninvasive staging of liver fibrosis with prevalent CKD in patients with NAFLD
The patients with CKD were older than those without CKD (55.7 ± 4.7 vs 51.7 ± 4.8, P < 0.001) and had higher levels of BMI, AST, ALT, serum uric acid (P < 0.001). They also had a higher prevalence of diabetes mellitus (25% vs 15.6%, P < 0.01). The FIB-4 score, ALT/AST ratio, and liver stiffness were significantly elevated in subjects with CKD, compared with those without CKD (P < 0.001), independently of the presence of diabetes mellitus ( Table 2 , Figure 2 ). The difference in systolic blood pressure (SBP) showed a strong tendency toward statistical significance (P = 0.051) between patients with or without CKD. There were no significant differences in gender, waist circumference, current smokers, diastolic blood pressure (DBP), GGT, PLT, TG, and LDL between these two groups. Table 3 .
| Multivariate analysis of the association of noninvasive staging of liver fibrosis with prevalent CKD in patients with NAFLD
Multivariate analysis using logistic model identified four independent indicators of CKD (Table 4) : age (OR = 1.19; 95%CI: 1.14- 
| D ISCUSS I ON
The major finding of this study was that NAFLD patients with a higher value of liver stiffness have an increased risk of chronic kidney Also, insulin resistance has been shown to be a contributor to the progression of kidney disease. In NAFLD patients, insulin resistance activates the sympathetic nervous system, sodium retention, and downregulation of the natriuretic peptide system, leading to impaired renal hemodynamics, making insulin resistance a potential mechanistic link between NAFLD and CKD. 1, 31 Additionally, atherosclerotic dyslipidemia in NAFLD has attracted considerable scientific interest.
Atherogenic dyslipidemia is common in NAFLD, which potentially increases the risk of atherosclerotic vascular that is associated with renal endothelial dysfunction and renovascular damage.
32
Given the cross-sectional design of the present study, whether there is a causal relationship between NAFLD and CKD has not yet been determined. However, in this study, after we adjusted for multiple potential confounding factors (age, serum uric acid, diabetes, liver stiffness), the positive relationship between NAFLD and CKD remain exists. This association might at least imply that CKD is not only a complication of the shared metabolic risk factors but CKD itself as a consequence induced by NAFLD. Furtherly, consistent with our finding, several prospective studies suggest that ultrasounddiagnosed NAFLD is an independent predictor of prevalent CKD. 28, 33 This study has some limitations. Firstly, the causality of the association between NAFLD and CKD could not be established, as this design of this study is cross-sectional. Secondly, the eGFR calculated by the 4-variable MDRD study equation as an indirect measured GFR was used to diagnose CKD. Although the possibility of underestimates renal function in obese subjects, the MDRD study equation has been a well-accepted means to estimate kidney function in epidemiologic studies. 20, 34, 35 Thirdly, the NAFLD was only diagnosed with ultrasonography but was not confirmed by liver biopsy. Nevertheless, it is not appropriate to perform liver biopsy in all NAFLD patients, particularly in a large sample of epidemiologic studies. 36, 37 Despite these limitations, this study has several strengths. First, this study has a relatively large sample size, ensuring enough power for detecting the potential role of noninvasive methods for identifying CKD. Second, a multivariate logistic analysis was used to adjust for multiple potential confounders. Third, this study adopts a onegates design, thus avoiding selection bias.
| CON CLUS ION
Our results suggest that liver stiffness is a potential indicator for CKD in ultrasonography-diagnosed NAFLD patients. Age, serum uric 
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